Back to the future: the managed care approach to rheumatoid arthritis.
Biologic disease-modifying antirheumatic drugs have been proven effective in the treatment of rheumatoid arthritis, but their efficacy literally comes at quite a high price to health plans. Therefore, MCOs are examining various strategies to provide coverage for these agents in a more cost-effective manner.